Form CORRESP - Correspondence:
SEC Accession No. 0001144204-19-031927
Filing Date
2019-06-21
Accepted
2019-06-21 17:12:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 10919
2 GRAPHIC image_007.jpg GRAPHIC 2561
  Complete submission text file 0001144204-19-031927.txt   15549
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

EIN.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)